Transcode Therapeutics Interest Expense

Interest Expense of Transcode Therapeutics is -83,200.00 USD in 2026.

Interest Expense of Transcode Therapeutics changed from -50,600.00 USD to -83,200.00 USD, representing a 64.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Transcode Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Transcode Therapeutics historically and in real time.